BE709011A - - Google Patents

Info

Publication number
BE709011A
BE709011A BE709011DA BE709011A BE 709011 A BE709011 A BE 709011A BE 709011D A BE709011D A BE 709011DA BE 709011 A BE709011 A BE 709011A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE709011A publication Critical patent/BE709011A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/12—Saturated ethers containing halogen
    • C07C43/123—Saturated ethers containing halogen both carbon chains are substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE709011D 1967-06-26 1968-01-05 BE709011A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR111950A FR1535615A (fr) 1967-06-26 1967-06-26 Procédé pour l'obtention de tétrahydro-1, 4-oxazines substituées en 2, 4 et en 2, 2, 4

Publications (1)

Publication Number Publication Date
BE709011A true BE709011A (cg-RX-API-DMAC10.html) 1968-07-05

Family

ID=8633844

Family Applications (1)

Application Number Title Priority Date Filing Date
BE709011D BE709011A (cg-RX-API-DMAC10.html) 1967-06-26 1968-01-05

Country Status (6)

Country Link
BE (1) BE709011A (cg-RX-API-DMAC10.html)
CH (1) CH487919A (cg-RX-API-DMAC10.html)
DE (1) DE1643857A1 (cg-RX-API-DMAC10.html)
FR (1) FR1535615A (cg-RX-API-DMAC10.html)
GB (1) GB1184023A (cg-RX-API-DMAC10.html)
NL (1) NL147728B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657476A1 (de) * 1976-12-18 1978-06-22 Basf Ag Morpholinderivate
FR2517305B1 (fr) * 1981-12-01 1985-10-25 Lafon Labor Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
FR2553412B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
DE3476386D1 (de) * 1983-11-02 1989-03-02 Beecham Group Plc Morpholine derivatives
CA2071897A1 (en) * 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
AU3364493A (en) * 1992-01-28 1993-09-01 Smithkline Beecham Plc Compounds as calcium channel antagonists
AU7177694A (en) * 1993-06-23 1995-01-17 Cambridge Neuroscience, Inc. Sigma receptor ligands and the use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (en) 2000-09-11 2003-06-18 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
CN101107235B (zh) * 2005-01-18 2011-03-16 霍夫曼-拉罗奇有限公司 作为5-ht2c激动剂的吗啉类化合物

Also Published As

Publication number Publication date
NL6801287A (cg-RX-API-DMAC10.html) 1968-12-27
FR1535615A (fr) 1968-08-09
GB1184023A (en) 1970-03-11
DE1643857A1 (de) 1971-04-15
CH487919A (fr) 1970-03-31
NL147728B (nl) 1975-11-17

Similar Documents

Publication Publication Date Title
BE709511A (cg-RX-API-DMAC10.html)
BE704512A (cg-RX-API-DMAC10.html)
BE699664A (cg-RX-API-DMAC10.html)
BE712410A (cg-RX-API-DMAC10.html)
BE692552A (cg-RX-API-DMAC10.html)
BE692374A (cg-RX-API-DMAC10.html)
NL6801287A (cg-RX-API-DMAC10.html)
BE709213A (cg-RX-API-DMAC10.html)
BE699317A (cg-RX-API-DMAC10.html)
BE701102A (cg-RX-API-DMAC10.html)
BE695898A (cg-RX-API-DMAC10.html)
BE704873A (cg-RX-API-DMAC10.html)
BE703950A (cg-RX-API-DMAC10.html)
BE710483A (cg-RX-API-DMAC10.html)
BE707701A (cg-RX-API-DMAC10.html)
BE707673A (cg-RX-API-DMAC10.html)
BE707187A (cg-RX-API-DMAC10.html)
BE706480A (cg-RX-API-DMAC10.html)
BE706097A (cg-RX-API-DMAC10.html)
BE707004A (cg-RX-API-DMAC10.html)
BE705929A (cg-RX-API-DMAC10.html)
BE709964A (cg-RX-API-DMAC10.html)
BE695914A (cg-RX-API-DMAC10.html)
BE697014A (cg-RX-API-DMAC10.html)
BE703584A (cg-RX-API-DMAC10.html)